Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.

[1]  H. Ngan,et al.  Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. , 2005, Cancer genetics and cytogenetics.

[2]  Minyoung Lee,et al.  AMP-activated Protein Kinase Activity Is Critical for Hypoxia-inducible Factor-1 Transcriptional Activity and Its Target Gene Expression under Hypoxic Conditions in DU145 Cells* , 2003, Journal of Biological Chemistry.

[3]  D. Saslow,et al.  The epidemiology of cervical cancer. , 2003, Cancer journal.

[4]  Bhuvanesh Singh,et al.  Comprehensive molecular cytogenetic characterization of cervical cancer cell lines , 2003, Genes, chromosomes & cancer.

[5]  M. Miyazaki,et al.  Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation , 2002, Oncogene.

[6]  Linqi Zhang,et al.  Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda. , 2002, AIDS research and human retroviruses.

[7]  H. Samaratunga,et al.  Expression analysis of δ‐catenin and prostate‐specific membrane antigen: Their potential as diagnostic markers for prostate cancer , 2002, International journal of cancer.

[8]  A. Zetterberg,et al.  Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas , 2002, Genes, chromosomes & cancer.

[9]  J. Saurat,et al.  The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. , 2001, The Journal of biological chemistry.

[10]  C. Culmsee,et al.  AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation , 2001, Journal of Molecular Neuroscience.

[11]  L. Mei,et al.  Erbin Is a Protein Concentrated at Postsynaptic Membranes That Interacts with PSD-95* , 2001, The Journal of Biological Chemistry.

[12]  G. Velasco,et al.  The AMP‐activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes , 2001, FEBS letters.

[13]  D J Campbell,et al.  AMP-activated protein kinase, super metabolic regulator. , 2001, Biochemical Society transactions.

[14]  T. Hwang,et al.  Metastatic renal cell carcinoma in a meningioma: a case report. , 2000, Journal of Korean medical science.

[15]  N. B. Atkin.  Significance of chromosome 5 and 17 changes in the development of carcinoma of the cervix uteri , 2000, Cytogenetic and Genome Research.

[16]  D. Birnbaum,et al.  ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor , 2000, Nature Cell Biology.

[17]  J. McDougall,et al.  Genomic changes and HPV type in cervical carcinoma. , 2000 .

[18]  T. Hwang,et al.  Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. , 1999, Journal of Korean medical science.

[19]  M. Schwab.  Oncogene amplification in solid tumors. , 1999, Seminars in cancer biology.

[20]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[21]  M. Christman,et al.  The Topoisomerase-related Function Gene TRF4 Affects Cellular Sensitivity to the Antitumor Agent Camptothecin* , 1999, The Journal of Biological Chemistry.

[22]  M. Beckmann,et al.  int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction. , 1997, Anticancer research.

[23]  K. Luettich,et al.  Epidermal growth factor receptor gene and c‐erbB‐2 gene amplification in ovarian cyst fluid , 1996, Obstetrics and gynecology.

[24]  M. Beckmann,et al.  ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin‐embedded breast carcinoma tissues , 1995, International journal of cancer.

[25]  R. Chaganti,et al.  Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. , 1995, Journal of the National Cancer Institute.

[26]  K. Oka,et al.  c‐erbB‐2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix , 1994, Cancer.

[27]  M. Silverstein,et al.  Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? , 1994, Cancer.

[28]  E. Liu,et al.  Differential polymerase chain reaction in the analysis of gene dosage. , 1993, Seminars in cancer biology.

[29]  A. Neubauer,et al.  Analysis of gene amplification in archival tissue by differential polymerase chain reaction. , 1992, Oncogene.

[30]  R. Fourney,et al.  Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. , 1991, Cancer research.

[31]  E. Liu,et al.  Detection of amplified oncogenes by differential polymerase chain reaction. , 1989, Oncogene.

[32]  A. Cheung,et al.  Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer. , 1999, European journal of cancer.

[33]  V. Marmol,et al.  Glutathione depletion in mouse melanoma cells increases their sensitivity to oxidative lysis , 1992 .